Evaluation of Treatment Response of Trans-Arterial Angioembolization of Plantar Artery in Patients with Plantar Fasciitis

Trans-Arterial Angioembolization of Plantar Artery with Ultrasound- Guided Arterial Puncture: Evaluation of Treatment Response in Patients with Plantar Fasciitis and Its Complications

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250715066507N1

Enrollment

Registered

2025-08-10

Start date

2025-07-31

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis.

Interventions

Intervention group: All procedures will be performed by interventional radiologists with at least one year of experience in ultrasound-guided injections and an orthopedic surgeon with one year of expe

Konica Minolta Japan, Inc., Tokyo, Japan) with an 11 MHz linear probe. Local anesthesia will be injected into the subcutaneous tissue adjacent to the PTA to ensure patient comfort during the procedure

Terumo Co., Inc., Tokyo, Japan) connected to an extension tube (SF-ET0525

Terumo Co., Inc., Tokyo, Japan) for precise access. The embolization agent, imipenem/cilastatin sodium (IPM/CS) (Merck & Co., Inc., Whitehouse Station, NJ), will be prepared for intra-arterial adminis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Local tenderness at the site where the plantar fascia attaches to the heel bone, plantar fascia thickness greater than 4 millimeters on ultrasound, symptoms persistent for at least two months despite conservative treatment, unilateral plantar fasciitis

Exclusion criteria

Exclusion criteria: Bilateral plantar fasciitis, local infection, coagulation disorders, recent trauma, incomplete follow-up data

Design outcomes

Primary

Measure	Time frame
Evaluation of pain relief in plantar fasciitis through angioembolization, changes in plantar fascia thickness, and the extent of fascia rupture in angioembolization. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: month.;Changes in plantar fascia thickness and the extent of its rupture in angioembolization. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: sonography.;NRS score. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: Questionnaire.;AOFAS score. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: Questionnaire.	—

Measure

Time frame

Evaluation of pain relief in plantar fasciitis through angioembolization, changes in plantar fascia thickness, and the extent of fascia rupture in angioembolization. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: month.;Changes in plantar fascia thickness and the extent of its rupture in angioembolization. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: sonography.;NRS score. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: Questionnaire.;AOFAS score. Timepoint: 1, 3, 6, 12, and 18 months post-surgery. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthamed qurani

Tehran University of Medical Sciences

hamedqurani@gmail.com+98 21 6658 1625

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026